UCHL-1 is not a Parkinson's disease susceptibility gene

Annals of Neurology

Volumn 59, Issue 4, 2006, Pages 627-633

  Healy, Daniel G ^a   Abou Sleiman, Patrick M ^a   Casas, Juan P ^b   Ahmadi, Kourosh R ^c   Lynch, Timothy ^d   Gandhi, Sonia ^a   Muqit, Miratul M K ^a   Foltynie, Thomas ^e   Barker, Roger ^e   Bhatia, Kailash P ^a   Quinn, Niall P ^a   Lees, Andrew J ^a,f   Gibson, J Mark ^g   Holton, Janice L ^a   Revesz, Tamas ^a   Goldstein, David B ^c   Wood, Nicholas W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MULTIGENE FAMILY; PARKINSON DISEASE; PRIORITY JOURNAL; UCHL1 GENE;

CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; FEMALE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; META-ANALYSIS; MIDDLE AGED; ODDS RATIO; PARKINSON DISEASE; POLYMORPHISM, GENETIC; SERINE; TYROSINE; UBIQUITIN THIOLESTERASE;

EID: 33645793947     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20757     Document Type: Article

References (30)

1. Leroy E, Boyer R, Auburger G, et al. The ubiquitin pathway in Parkinson's disease. Nature 1998;395:451-452.
2. Maraganore DM, Farrer MJ, Hardy JA, et al. Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease. Neurology 1999;53:1858-1860.
3. Satoh J, Kuroda Y. A polymorphic variation of serine to tyrosine at codon 18 in the ubiquitin C-terminal hydrolase-L1 gene is associated with a reduced risk of sporadic Parkinson's disease in a Japanese population. J Neurol Sci 2001;189:113-117.
4. Momose Y, Murata M, Kobayashi K, et al. Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms. Ann Neurol 2002;51:133-136.
5. Wintermeyer P, Kruger R, Kuhn W, et al. Mutation analysis and association studies of the UCHL1 gene in German Parkinson's disease patients. Neuroreport 2000;11:2079-2082.
6. Zhang J, Hattori N, Leroy E, et al. Association between a polymorphism of ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) gene and sporadic Parkinson's disease. Parkinsonism Rel Disord 2000;6:195-197.
7. Elbaz A, Levecque C, Clavel J, et al. S18Y polymorphism in the UCH-L1 gene and Parkinson's disease: evidence for an age-dependent relationship. Mov Disord 2003;18:130-137.
8. Mellick GD, Silburn PA. The ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism does not confer protection against idiopathic Parkinson's disease. Neurosci Lett 2000;293:127-130.
9. Savettieri G, De Marco EV, Civitelli D, et al. Lack of association between ubiquitin carboxy-terminal hydrolase L1 gene polymorphism and PD. Neurology 2001;57:560-561.
10. Wang J, Zhao CY, Si YM, et al. ACT and UCHL-1 polymorphisms in Parkinson's disease and age of onset. Mov Disord 2002;17:767-771.
11. Levecque C, Destee A, Mouroux V, et al. No genetic association of the ubiquitin carboxy-terminal hydrolase-L1 gene S18Y polymorphism with familial Parkinson's disease. J Neural Transm 2001;108:979-984.
12. Gasser T, Pilz P, Omasmeier D, et al. Ubiquitin C-terminal hydrolase L1 in sporadic Parkinson's disease. Mov Disord 2000;15:A201.
13. Maraganore DM, Lesnick TG, Elbaz A, et al. UCHL1 is a Parkinson's disease susceptibility gene. Ann Neurol 2004;55:512-521.
14. Liu Y, Fallon L, Lashuel HA, Liu Z, Lansbury PT Jr. The UCHL-1 gene encodes two opposing enzymatic activities that affect alpha synuclein degradation and Parkinson's disease susceptibility. Cell 2002;111:209-218.
15. Goldstein DB, Ahmadi KR, Weale ME, Wood NW. Genome scans and candidate gene approaches in the study of common diseases and variable drug responses. Trends Genet 2003;19:615-622.
16. Weale ME, Depondt C, Macdonald SJ, et al. Selection and evaluation of tagging SNPs in the neuronal-sodium-channel gene SCN1A: implications for linkage-disequilibrium gene mapping. Am J Hum Genet 2003;73:551-565.
17. Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-754.
18. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
19. Centre d'Etude du Polymorphisme Humain (CEPH) database. Available at: http://www.cephb.fr. Accessed 12/30/05.
20. Tagging SNP software. Available at: http://www.genome. duke.edu. Accessed.
21. Healy DG, Abou-Sleiman PM, Ahmadi KR, et al. The gene responsible for PARK6 Parkinson's disease, PINK1, does not influence common forms of parkinsonism. Ann Neurol 2004;56:329-335.
22. Zhao JH, Curtis D, Sham PC. Model-free analysis and permutation tests for allelic associations. Hum Hered 2000;50:133-139.
23. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-748.
24. DerSimonian R, Laird NM. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
25. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001;29:306-309.
26. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003;19:149-150.
27. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003;19:149-150.
28. Li Y, Hollingworth P, Moore P, et al. Genetic association of the APP binding protein 2 gene (APBB2) with late onset Alzheimer disease. Hum Mutat 2005;25:270-277.
29. Pattyn A, Morin X, Cremer H, et al. The homeobox gene Phox2b is essential for the development of autonomie neural crest derivatives. Nature 1999;399:366-370.
30. Dahlman I, Eaves IA, Kosoy R, et al. Parameters for reliable results in genetic association studies in common disease. Nat Genet 2002;3:149-150.